Tissue Regenix Wound Care is a Britain-based medical device company that opened its American subsidiary in San Antonio last year.
The product, which helps heal chronic and acute wounds, will be available to hospitals and U.S. Department of Veterans Affairs healthcare facilities, according to the report.
More Articles on Supply Chain:
MiMedx Group Supports CMS’s New Skin Substitute Reimbursement Methodology
Amerinet, Richard Wolf Enter Into Endoscopic Products Partnership
Janssen Therapeutics’ OLYSIO Inhibitor Receives FDA Approval for Hepatitis C Treatments
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
